CTRI/2019/11/021961尚未招募4 期
Comparison of efficacy and safety of azilsartan and amlodipine versus telmisartan and amlodipine in hypertensive patients-A non-inferiority study
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of either sex aged between 30 â?? 65 years.
- •Hypertensive patients who had not achieved target BP levels as defined by JNC 8 with monotherapy for at least one month
- •Willing to participate by giving written informed consent.
- •Hypertensive patients with other comorbidities
排除标准
- •Patients diagnosed with secondary hypertension
- •Patients of hypertensive emergency and hypertensive urgency
- •Presence of hyperkalaemia (potassium level >= 5.5 mEq)
- •Pregnant and lactating women
- •Patient history of allergic to Azilsartan, Telmisartan, and Amlodipine
- •Any serious hepatic, cardiovascular, renal or pulmonary condition which may prevent participation in the study
- •Any drug having an adverse interaction with azilsartan, telmisartan, and amlodipine in term of safety and efficacy.
- •Patients diagnosed with Type 1 DM.
- •Type 2 Diabetic patients with HbA1c > 8.5%
研究者
相似试验
已完成
不适用
Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertensioHypertensionJPRN-UMIN000016249Department of Cardiology, Fukuoka University School of Medicine60
已完成
不适用
A clinical trial to study the effects of two drugs,Azilsartan and Losartan in patients with high blood pressureCTRI/2020/08/027209PIMS105
招募中
不适用
Evaluation for Efficacy and Safety of Azilsartan in Patients with HypertensioEssential HypertensionJPRN-UMIN000008577Department of Medicine and Bioregulatory SciencesThe University of Tokushima, Graduate School of Health Biosciences30
尚未招募
4 期
TO COMPARE THE SAFETY & EFFICACY OF AZILSARTAN VERSUS OLMESARTAN AS ADD ON THERAPY TO CHLORTHALIDONE IN COEXISTING HYPERTENSION WITH TYPE-2 DIABETES MELLITUS RANDOMISED CONTROLLED TRIACTRI/2020/04/024756DR DEEKSHA SHARMA
已完成
不适用
Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan.Type 2 diabetes mellitus with hypertensionJPRN-UMIN000010604Iwasaki Naika Clinic20